Open access

Prologue on DISEASES OF DOGS - for Practioners

Written By

Mani Saravanan

Submitted: October 11th, 2018 Published: March 11th, 2020

DOI: 10.5772/intechopen.88479

From the Edited Volume

Veterinary Medicine and Pharmaceuticals

Edited by Samuel Oppong Bekoe, Mani Saravanan, Reimmel Kwame Adosraku and P K Ramkumar

Chapter metrics overview

501 Chapter Downloads

View Full Metrics

1. Introduction

Pet animals play a vital role in the human society as a companion, stress buster, guarding, etc. Health-care management of such pet animals is very much essential. Hence the pet animal clinical practice is a challenge to relive the suffering of the pet and to restore its normal routines. In recent years on par with human medicine, newer diagnostic technique and therapeutic protocols were followed to cure various diseases and condition of animals. Ascites, duodenal disorders, canine mastitis and re-emerging disease like Babesia are a timely needed topic in the day to day activities of pet animal clinical practices. This book provides the information on ascites, Babesia, duodenal disorders and mastitis of canines.


2. Ascites

Small animal clinicians are frequently presented with abdominal abnormalities. In many cases these abnormalities result from primary intra-abdominal disease, although the clinical signs may be an abdominal manifestation of extra-abdominal disease [1]. Ascites is usually accompanied with chronic hepatic damage, as a result of portal hypertension, hypoalbuminaemia and increased renal sodium and water retention. It also occurred in congestive heart failure, protein losing enteropathy, protein losing nephropathy, neoplasia, peritonitis, haemorrhage, and rupture of gall bladder or urinary bladder [2]. Ascites occurs when there is an alteration in starling’s forces, including increased venous or lymphatic hydrostatic pressure, vascular permeability, increased intraperitoneal oncotic pressure and decreased capillary oncotic pressure [3].

The diagnosis of liver disorders is often very vague and non-specific, especially in the early or mild stage of hepatobiliary diseases, because the clinical signs do not correlate with hepatic parenchyma damage. In the varied functional activities of liver, there was no single test that can accurately identify hepatic damage or its underlying cause; hence, a set of tests are necessary to assess ascites due hepatobiliary disorder. Liver dysfunction can be diagnosed and monitored by hepatic markers, hepatic blood flow estimation, prothrombin time, serum bilirubin, transaminases [4], serum alkaline phosphatise, γ-glutamyl transferase [5], glucose [6], total protein and albumin levels [7]. Complete blood counts, serum biochemical profile, urine analysis, faecal analysis and survey of abdominal radiography or ultrasonography [8] are being considered for screening value.

The gross appearance of the fluid may be helpful in determining the pathological process. Examination of ascitic fluid consists of colour, specific gravity, total protein, albumin, nucleated cell count and serum ascitic albumin gradient (SAAG). The actual cause of ascites is a greater difficulty to the clinicians [9].

Extensive literature has been published in various animals on ascites of hepatobiliary dysfunctions and their remedies. The main aim of the treatment protocol is to eliminate the causative factors by reducing hepatic inflammation, fibrosis and hepatic regeneration and curtail its complications. Low sodium diet and diuretics, namely, furosemide and spironolactone, are the most commonly used to reduce ascites. Certain animals failed to respond diuretics due to high serum aldosterone liver cirrhosis [10]. The consequence of ascites due to hepatobiliary disorders are refractory ascites and hepatorenal syndrome (HRS), which leads short survival of patient [11]. Abdominocentesis is performed if the ascites is life-threatening [12]. Other therapeutic management of ascites in humans are large volume paracentesis, intravenous albumin infusion, transjugular intrahepatic portosystemic shunt (TIPS), peritoneovenous shunt and liver transplantation [11, 13]. But these therapeutic measures are under experiment in animals, and each of the methods has its own disadvantage, that is, incomplete recovery from ascites and cost-ineffective.


3. Canine mastitis

Inflammation of the mammary gland is a common problem in bitches. It’s caused by bacterial and fungal pathogens along with immunodeficiency [14, 15]. The clinical manifestation of mastitis is classified as acute, chronic, subclinical and gangrenous mastitis. Causes for the mastitis are poor hygienic, trauma and systemic infections. The most common route of infection is the ascending route followed by trauma and haematogenous route [16].

Complete physical examination of mammary glands should be done for their symmetry, temperature, size, consistency and colour. In the case of abnormal milk secretion, evaluate its colour, consistency and smell. Cytological examination of milk should be performed. In chronic mastitis a microbiological culture of the milk and antibiotic sensitivity should be performed to identify the pathogens and initiate the appropriate therapeutic protocols. The most common isolated pathogens are staphylococci, streptococci and E. coli in mastitis milk [16]. Mammary radiography and ultrasound examination are also recommended for such case to neoplasia and to exclude metastases to the lungs. Fine-needle biopsy is usually recommended if mammary neoplasia is suspected, though useful.

FNAC can precisely assess the degree of inflammation as well as detect abnormalities inside the mammary gland [17]. Acute phase proteins (CRP or SAA) in serum and milk samples seem to be the most accurate inflammatory biomarkers to diagnose canine mastitis, as their concentrations are significantly higher in bitches suffering from mastitis than in healthy bitches. Other inflammatory biomarkers like cyclooxygenases or interleukins seem to be promising both in diagnosis of mastitis and differentiation between mastitis and mammary tumours [18].


4. Babesiosis

Babesiosis is one among the deadly tick-borne haemaprotozoan infection in dogs. Causative agents of canine babesiosis are Babesia canis, B. gibsoni and B. vogeli [19]. Babesia infection could cause autoimmune disorder like immune-mediated haemolytic anaemia (IMHA) and immune-mediated thrombocytopenia (IMTP) in dogs, and it may occur individually or concurrently. If they occur together, they call it as Evans syndrome [20]. Evans syndrome with Babesia in canines leads to the destruction of RBCs and platelets, oxidative stress and endothelial injury [21, 22]. Flow cytometry method is considered to be more rapid, cost-effective, sensitive methods to diagnose IMHA and ITP in humans and animals [23, 24].


5. Duodenal disorders

Commonly recorded canine duodenal disorders are inflammatory bowel disease, lymphangiectasia, ulcer, foreign body, giardia, parasites, small intestinal bacterial overgrowth and neoplasia [25]. Duodenal disorders are difficult to identify clinically because of the non-specific symptoms. They may or may not be identifiable through routine radiographic, ultrasonographic or laboratory evaluation methods, because many diseases of duodenum primarily involve the mucosal surface. Thus diagnosis and treatment of the duodenal disorders are challenging for the canine practitioners [26]. Duodenoscopy is an efficient way of identifying the abnormalities of mucosal irregularities and obtaining mucosal biopsy and duodenal juice for routine histopathological and bacteriological studies [27, 28, 29].


6. Conclusions

  • Newer therapeutic modalities may emerge to incorporate alternative medicine into an integrated medical approach with standard therapy against liver disorders.

  • PCR is essential to rule out tick-borne infection in dogs, and flow cytometry is a sensitive method to diagnose IMHA and IMTP.

  • Visualization of duodenal epithelium and obtaining intestinal mucosal biopsy by duodenoscopy are an ideal tool in the diagnosis of duodenal disorders.


  1. 1. Hunt GB. Abdominal condition of the dog and cat. In: 27th WSAVA congress. Grananda, Spain; 2002. pp. 3-6
  2. 2. Rutgers C, Biourge V. Nutrition of dogs with liver disease. In: Pibot P, Biourge V, Elliott D, editors. Encyclopedia of Canine Clinical Nutrition. Aimargues, France: Aniwa SAS; 2006. pp. 134-161
  3. 3. Richter KP. Disease of the liver and hepato biliary system. In: Jam TR, editor. Hand Book of Small Animal Gastroenterology. 2nd ed. St. Louish, Missouri: Saunders; 2003. pp. 379-381
  4. 4. Kamble MB, Dumbre RK, Rangari VD. Hepatoprotective activity studies of herbal formulations. International Journal of Green Pharmacy. 2009;20:147-151
  5. 5. El-Segaey O, Ab-Allah A, Al-Nooman SA. Experimental study of antioxidant and hepatoprotective effects of clove and cardamom in ethanol induced hepatoxicity. Tanta Medical Sciences Journal. 2007;2(1):27-36
  6. 6. Banerjee S. Significance of Hepatic Copper Values in Dogs with Hepatitis. Chennai: TANUVAS; 2003
  7. 7. Tiwari P, Varshney JP, Hoque M. Biliary obstruction in dogs: Diagnosis and treatment. Indian Journal of Veterinary Medicine. 2001;21(2):115-116
  8. 8. Varshney JP, Hoque M. Clinicopathological and ultrasonographic observation in canine hepatopathies. The Indian Journal of Animal Sciences. 2002;72(6):423-427
  9. 9. Bjelakoviv G, Tasie T, Stamenkoviv I, Katie V, Otasinoviv M, Bjelankovic G. Biochemical, cytological and microbiological characteristics of the cirrhotic, malignant and mixed ascites. Archive of Oncology. 2001;9:95-101
  10. 10. Center SA. Fluid, electrolyte and acid—Base disturbances in liver disease. In: Dlbartola SP, editor. Fluid, Electrolyte and Acid Base Disorders in Small Animal Practice. 3rd ed. St. Louis, Missouri: Sanders Elsevier; 2006. pp. 437-473
  11. 11. Salerno F, Guevava M, Bernardi M, Morean R, Wong F, Angeli P, et al. Refractory ascites; pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver International. 2010;30(7):937-947
  12. 12. Bexfield N, Watson P. Treatment of canine liver disease, 2. Managing clinical signs and specific liver disease. In Practice. 2009;31:172-180
  13. 13. Burgees LJ. Biochemical analysis of pleural, peritoneal and pericardial effusion—Review. Clinica Chimica Acta. 2004;343:61-81
  14. 14. Ditmyer H, Craig L. Mycotic mastitis in three dogs due to Blastomyces dermatitidis. Journal of the American Animal Hospital Association. 2011;47(5):356-358
  15. 15. Murai A, Maruyama S, Nagata M, Yuki M. Mastitis caused by Mycobacterium kansasii infection in a dog. Veterinary Clinical Pathology. 2013;42:377-381
  16. 16. Marti JA, Fernandez S. Clinical approach to mammary gland disease. In: England G, von Heimendahl A, editors. BSVA Manual of Canine and Feline Reproduction and Neonatology. ed. 2 ed. Gloucester: British Small Animal Veterinary Association; 2010. p. 155
  17. 17. Trasch K, Wehrend A, Bostedt H. Ultrasonographic description of canine mastitis. Veterinary Radiology & Ultrasound. 2007;48:580-584
  18. 18. Kaszak I, Ruszczak A, Kanafa S, Piłaszewicz OW, Sacharczuk M, Jurka P. New insights of canine mastitis—A review. Animal Science Papers and Reports. 2018;36(1):33-44
  19. 19. Breitschwerte E. Babesiosis. In: Clinical Microbiology and Infectious Diseases of the Dog and Cat. Philadelphia: WB Saunders; 1984. pp. 796-805
  20. 20. Norkus C. Chapter 11: Specific organ system disorders. In: Campbell M, editor. Veterinary Technician’s Manual for Small Animal Emergency and Critical Care. Ames, Iowa: Wiley-Blackwell; 2012. pp. 243-252
  21. 21. Wingfield W, Raffe M. Chapter 46: Immune-mediated hemolytic anemia. In: Faudskar L, Jackson WY, editors. Veterinary ICU Book. USA: Teton New Media; 2002. pp. 710-720
  22. 22. Di Cicco MF, Birkenheuer AJ. Canine babesiosis—Peer reviewed. In: NAVC Clinician’s Brief. 2012. pp. 31-35
  23. 23. Quigley KA, Chelack BJ, Haines DM, Jackson ML. Application of a direct flow cytometric erythrocyte immunofluorescence assay in dogs with immune-mediated hemolytic anemia and comparison to the direct antiglobulin test. Journal of Veterinary Diagnostic Investigation. 2001;13(4):297-300
  24. 24. Dircks BH, Schuberth HJ, Mischke R. Underlying diseases and clinicopathologic variables of thrombocytopenic dogs with and without platelet-bound antibodies detected by use of a flow cytometric assay: 83 cases (2004-2006). Journal of the American Veterinary Medical Association. 2009;235(8):960-966
  25. 25. Zoran LD. Gastroduodenoscopy in dog and cat. The Veterinary Clinics of North America. Small Animal Practice. 2001;31:631-656
  26. 26. Jergens AE. Clinical assessment of disease activity for canine inflammatory bowel disease. Journal of the American Animal Hospital Association. 2004;40:437-445
  27. 27. Day MJ, Bilzer T, Mansell J, Wilcock B, Hall EJ, Jergens A, et al. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: A report from the world small animal veterinary association gastrointestinal standardization group. Journal of Comparative Pathology. 2008;138(Suppl. 1):S1-S43
  28. 28. Ridgway J, Jergens AE, NIyo Y. Possible causal association of idiopathic inflammatory bowel disease with thrombo cytopenia in the dog. Journal of the American Animal Hospital Association. 2001;37:65-74
  29. 29. Twet DC. Perspective on gastrointestinal endoscopy. The Veterinary Clinics of North America. Small Animal Practice. 1993;23:481-495

Written By

Mani Saravanan

Submitted: October 11th, 2018 Published: March 11th, 2020